Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Association between Living Kidney Donor Post-Donation Hypertension and Recipient Graft Failure.

Holscher CM, Ishaque T, Haugen CE, Jackson KR, Garonzik Wang JM, Yu Y, Al Ammary F, Segev DL, Massie AB.

Transplantation. 2019 Jul 15. doi: 10.1097/TP.0000000000002832. [Epub ahead of print]

PMID:
31335778
2.

Risk of ESKD in Older Live Kidney Donors with Hypertension.

Al Ammary F, Luo X, Muzaale AD, Massie AB, Crews DC, Waldram MM, Qadi MA, Garonzik-Wang J, Henderson ML, Brennan DC, Wiseman AC, Lindrooth RC, Snyder JJ, Coresh J, Segev DL.

Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1048-1055. doi: 10.2215/CJN.14031118. Epub 2019 Jun 25.

PMID:
31239252
3.

The changing landscape of live kidney donation in the United States from 2005 to 2017.

Al Ammary F, Bowring MG, Massie AB, Yu S, Waldram MM, Garonzik-Wang J, Thomas AG, Holscher CM, Qadi MA, Henderson ML, Wiseman AC, Gralla J, Brennan DC, Segev DL, Muzaale AD.

Am J Transplant. 2019 Sep;19(9):2614-2621. doi: 10.1111/ajt.15368. Epub 2019 May 3.

PMID:
30903733
4.

The landscape of international living kidney donation in the United States.

Al Ammary F, Thomas AG, Massie AB, Muzaale AD, Shaffer AA, Koons B, Qadi MA, Crews DC, Garonzik-Wang J, Fang H, Brennan DC, Lentine KL, Segev DL, Henderson ML.

Am J Transplant. 2019 Jul;19(7):2009-2019. doi: 10.1111/ajt.15256. Epub 2019 Feb 8.

PMID:
30615253
5.

Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States.

Holscher CM, Luo X, Massie AB, Purnell TS, Garonzik Wang JM, Bae S, Henderson ML, Al Ammary F, Ottman SE, Segev DL.

Am J Transplant. 2019 Jan;19(1):269-276. doi: 10.1111/ajt.15126. Epub 2018 Oct 16.

PMID:
30253051
6.

Living donor postnephrectomy kidney function and recipient graft loss: A dose-response relationship.

Holscher CM, Ishaque T, Garonzik Wang JM, Haugen CE, DiBrito SR, Jackson KR, Muzaale AD, Massie AB, Al Ammary F, Ottman SE, Henderson ML, Segev DL.

Am J Transplant. 2018 Nov;18(11):2804-2810. doi: 10.1111/ajt.15061. Epub 2018 Aug 31.

PMID:
30086198
7.

Racial differences in completion of the living kidney donor evaluation process.

Kumar K, Tonascia JM, Muzaale AD, Purnell TS, Ottmann SE, Al Ammary F, Bowring MG, Poon A, King EA, Massie AB, Chow EKH, Thomas AG, Ying H, Borja M, Konel JM, Henderson M, Cameron AM, Garonzik-Wang JM, Segev DL.

Clin Transplant. 2018 Jul;32(7):e13291. doi: 10.1111/ctr.13291. Epub 2018 Jun 15.

8.

Mortality and Graft Loss Attributable to Readmission After Kidney Transplantation: Immediate and Long-term Risk.

King EA, Bowring MG, Massie AB, Kucirka LM, McAdams-DeMarco MA, Al-Ammary F, Desai NM, Segev DL.

Transplantation. 2017 Oct;101(10):2520-2526. doi: 10.1097/TP.0000000000001609.

9.

Early Hospital Readmission After Simultaneous Pancreas-Kidney Transplantation: Patient and Center-Level Factors.

King EA, Kucirka LM, McAdams-DeMarco MA, Massie AB, Al Ammary F, Ahmed R, Grams ME, Segev DL.

Am J Transplant. 2016 Feb;16(2):541-9. doi: 10.1111/ajt.13485. Epub 2015 Oct 16.

10.

Role of diuretics and ultrafiltration in congestive heart failure.

Shchekochikhin D, Al Ammary F, Lindenfeld JA, Schrier R.

Pharmaceuticals (Basel). 2013 Jul 4;6(7):851-66. doi: 10.3390/ph6070851.

11.

Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model.

Johnstone MT, Perez AS, Nasser I, Stewart R, Vaidya A, Al Ammary F, Schmidt B, Horowitz G, Dolgoff J, Hamilton J, Quist WC.

Circulation. 2004 Oct 5;110(14):2060-5. Epub 2004 Sep 27.

Supplemental Content

Loading ...
Support Center